Ahmet Küçükarda

About Ahmet Küçükarda

Ahmet Küçükarda, With an exceptional h-index of 6 and a recent h-index of 6 (since 2020), a distinguished researcher at Trakya Üniversitesi, specializes in the field of medical oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium

Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenib

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium …

JOURNAL of ONCOLOGICAL SCIENCES

Where Should Enzalutamide Be in The Metastatic Castration Resistant Prostate Cancer (mCRPC): A Multi-center Study

An experimental study: the effect of S. boulardii on abemaciclib-induced diarrhea

Prognostic Effect of Immunohistochemical Scoring on Survival in Glioblastoma.

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Ahmet Küçükarda Information

University

Position

___

Citations(all)

165

Citations(since 2020)

158

Cited By

40

hIndex(all)

6

hIndex(since 2020)

6

i10Index(all)

5

i10Index(since 2020)

4

Email

University Profile Page

Google Scholar

Ahmet Küçükarda Skills & Research Interests

medical oncology

Top articles of Ahmet Küçükarda

Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium

Urologia Internationalis

2023

Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenib

Journal of Cancer Research and Therapeutics

2023/4/1

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium …

Clinical Genitourinary Cancer

2023/2/1

JOURNAL of ONCOLOGICAL SCIENCES

2017/6/3

Where Should Enzalutamide Be in The Metastatic Castration Resistant Prostate Cancer (mCRPC): A Multi-center Study

Eurasian Journal of Medicine and Oncology

2023

An experimental study: the effect of S. boulardii on abemaciclib-induced diarrhea

Turkish Journal of Medical Sciences

2023

Prognostic Effect of Immunohistochemical Scoring on Survival in Glioblastoma.

Eurasian Journal of Medical Investigation

2023/1/1

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Journal of cancer research and therapeutics

2022/12/1

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and …

Journal of Cancer Research and Clinical Oncology

2022/12

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

Anatolian Current Medical Journal

2023/1/1

The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study

Medicine

2022/9/2

Effects of Cytoreductive Nephrectomy on Nivolumab Outcomes in Patients with Metastatic Clear Cell Renal Carcinoma: A Retrospective Observational Real-Life Data of Turkish …

2022/6/8

Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated …

Actas Urológicas Españolas (English Edition)

2022/6/1

El índice nutricional pronóstico como factor pronóstico independiente para la respuesta al tratamiento, la supervivencia y la elección del fármaco en el cáncer de próstata …

Actas Urológicas Españolas

2022/6/1

Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma

Immunotherapy

2022/4/1

Ahmet Küçükarda
Ahmet Küçükarda

H-Index: 3

Erkan Özcan
Erkan Özcan

H-Index: 3

Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma

Tumori Journal

2022/4

Prognostic Factors for Survival in Transverse Colon Cancers

Journal of Gastrointestinal Cancer

2022/3

Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma

Supportive Care in Cancer

2022/3/1

Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

2022/3/12

Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

2021/2/20

See List of Professors in Ahmet Küçükarda University(Trakya Üniversitesi)

Co-Authors

academic-engine